4.3 Article

Acute and chronic metabolic effects of carvedilol in high-fructose, high-fat diet-fed mice: implication of β-arrestin2 pathway

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Carvedilol Diminishes Cardiac Remodeling Induced by High-Fructose/High-Fat Diet in Mice via Enhancing Cardiac β-Arrestin2 Signaling

Wael S. Ibrahim et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2020)

Article Endocrinology & Metabolism

Isoproterenol Induced Insulin Resistance Leading to Diabetic Ketoacidosis in Type 1 Diabetes Mellitus

Ryan Hoff et al.

CASE REPORTS IN ENDOCRINOLOGY (2018)

Review Cardiac & Cardiovascular Systems

G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms

Pierre-Yves Jean-Charles et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)

Article Biochemistry & Molecular Biology

Comparison of free-radical inhibiting antioxidant properties of carvedilol and its phenolic metabolites

Thomas C. Malig et al.

MEDCHEMCOMM (2017)

Article Biotechnology & Applied Microbiology

Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats

Mohamed A. Morsy et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Article Pharmacology & Pharmacy

Ezrin, Radixin, and Moesin Phosphorylation in NIH3T3 Cells Revealed Angiotensin II Type 1 Receptor Cell-Type Dependent Biased Signaling

Islam A. A. E-H Ibrahim et al.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2013)

Article Endocrinology & Metabolism

Role of β-adrenergic receptors in regulation of hepatic fat accumulation during aging

Paramita M. Ghosh et al.

JOURNAL OF ENDOCRINOLOGY (2012)

Article Cardiac & Cardiovascular Systems

High-carbohydrate, High-fat Diet–induced Metabolic Syndrome and Cardiovascular Remodeling in Rats: Erratum

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)

Review Chemistry, Medicinal

Free Fatty Acid Receptors FFAR1 and GPR120 as Novel Therapeutic Targets for Metabolic Disorders

Takafumi Hara et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2011)

Review Pharmacology & Pharmacy

Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases

Saswata Talukdar et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2011)

Article Multidisciplinary Sciences

Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance

Bing Luan et al.

NATURE (2009)

Article Pharmacology & Pharmacy

Impact of carvedilol on the serum lipid profile

Randall P. Sharp et al.

ANNALS OF PHARMACOTHERAPY (2008)

Article Pharmacology & Pharmacy

Free fatty acid receptors and drug discovery

Akira Hirasawa et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)

Article Biochemistry & Molecular Biology

β-arrestin scaffolding of phosphatidylinositol 4-phosphate 5-kinase Iα promotes agonist-stimulated sequestration of the β2-adrenergic receptor

Christopher D. Nelson et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Nutrition & Dietetics

Lipid Mediators of Insulin Resistance

William L. Holland et al.

NUTRITION REVIEWS (2008)

Article Multidisciplinary Sciences

A unique mechanism of β-blocker action:: Carvedilol stimulates β-arrestin signaling

James W. Wisler et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Endocrinology & Metabolism

Overexpression of β2-adrenergic receptors in mouse liver alters the expression of gluconeogenic and glycolytic enzymes

L Erraji-Benchekroun et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)

Article Medicine, General & Internal

Trends in cardiovascular complications of diabetes

CS Fox et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)

Article Physiology

Epinephrine inhibits insulin-stimulated muscle glucose transport

DG Hunt et al.

JOURNAL OF APPLIED PHYSIOLOGY (2002)

Article Multidisciplinary Sciences

β-Arrestin 2:: A receptor-regulated MAPK scaffold for the activation of JNK3

PH McDonald et al.

SCIENCE (2000)